Product correctly added to cart.

discount label
ART558
View 3D

Biosynth logo

ART558

CAS: 2603528-97-6

Ref. 3D-DEE52897

5mg
307.00 €
10mg
430.00 €
25mg
569.00 €
50mg
814.00 €
100mg
1,155.00 €
Estimated delivery in United States, on Friday 20 Dec 2024

Product Information

Name:
ART558
Description:

ART558 is a potent inhibitor of kinases, specifically targeting cyclin-dependent kinases (CDKs). It has been extensively studied for its potential use in cancer treatment. ART558 works by inhibiting the activity of CDKs, which are proteins that regulate cell division and growth. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. ART558 has shown promising results in preclinical studies against a variety of human cancers, including lung and breast tumors. Additionally, it has been found to be effective against Chinese hamster ovary cells and other tumor cells. ART558 is being developed as an anticancer drug candidate due to its medicinal properties and potential as a targeted therapy for cancer patients.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
418.4 g/mol
Formula:
C21H21F3N4O2
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-DEE52897 ART558

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".